Literature DB >> 10566737

How often does ultrasound marking change the liver biopsy site?

T R Riley1.   

Abstract

OBJECTIVES: The aim of this study was to answer the question: How often does ultrasound change the liver biopsy position, when a percussion technique is applied, because of intervening structures? A secondary objective is to compare the performance of the hepatologist to a radiology technician to demonstrate safety of a self-training technique.
METHODS: One hundred sixty-five consecutive outpatient liver biopsies were studied. Using a standard percussion technique, a biopsy site was chosen and marked. Ultrasound was applied to the marked site. An adequate site was determined to be one without intervening structure within 6 cm of liver depth. If an intervening structure was found, an alternative site was chosen by ultrasound. Data recorded included reason for change of position, distance of moved site from original site, and complications. The first third of liver biopsies were done with assistance of a certified radiology technician performing ultrasound, the last two-thirds were done by the hepatologist after observing the first 64 biopsies.
RESULTS: Ultrasound changed the position in 21 of 165 patients. The ultrasound caused an abortion of the procedure in 4 of 165 patients. Ultrasound changed management in 15.1% of patients. Reasons for change were lung (10 patients), gallbladder (6), large central vessel (4), >4-cm rim of ascites (2), colonic loop (1), slim liver edge (1), and focal liver lesions (1 patient). There was a 1.8% multiple pass rate. No serious complications occurred.
CONCLUSIONS: Ultrasound changed management 15.1% of patients. A hepatologist could perform ultrasound marking after a period of observation, without compromising results. A low multiple pass rate was observed when applying ultrasound and percussion. Avoided structures could explain decrease in pain when ultrasound is applied.

Entities:  

Mesh:

Year:  1999        PMID: 10566737     DOI: 10.1111/j.1572-0241.1999.01545.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  14 in total

1.  Percutaneous liver biopsy: what is the current approach? Results of a questionnaire survey.

Authors:  W Mayoral; J H Lewis
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 2.  Liver biopsy: when, how, by whom, and where?

Authors:  D B McGill
Journal:  Curr Gastroenterol Rep       Date:  2001-02

3.  Predictors of pain medication use after percutaneous liver biopsy.

Authors:  Thomas R Riley
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

4.  Trends in the indication and method of liver biopsy for hepatitis B and C.

Authors:  Michael J Lipp; Lionel S D'Souza; David J Clain; Henry C Bodenheimer; Albert D Min
Journal:  Dig Dis Sci       Date:  2010-07-15       Impact factor: 3.199

5.  Bedside ultrasound can predict nonalcoholic fatty liver disease in the hands of clinicians using a prototype image.

Authors:  Thomas R Riley; Alfredo Mendoza; Michael A Bruno
Journal:  Dig Dis Sci       Date:  2006-06-17       Impact factor: 3.199

6.  Percutaneous liver biopsy: reflections and refinements.

Authors:  Cameron N Ghent
Journal:  Can J Gastroenterol       Date:  2006-02       Impact factor: 3.522

7.  The effect of processing on liver biopsy core size.

Authors:  Thomas R Riley; Francesca M Ruggiero
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

8.  The safety of same-day endoscopy and percutaneous liver biopsy.

Authors:  Jonathan G Stine; Gordon Liss; James H Lewis
Journal:  Dig Dis Sci       Date:  2010-09-21       Impact factor: 3.199

9.  Safety of blind liver biopsy.

Authors:  A S M Bazlul Karim; Mizanur Rahman
Journal:  Indian J Pediatr       Date:  2004-10       Impact factor: 1.967

Review 10.  Why, who and how should perform liver biopsy in chronic liver diseases.

Authors:  Ioan Sporea; Alina Popescu; Roxana Sirli
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.